Occuity Revenue and Competitors

Occuity's mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimer's Disease.\n\n\nOccuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored.\n \nOccuity's IP includes 9granted international patents with a further 5 applications.\n \nOur Products\n\nOptometry & Ophthalmology:\nWe're designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 202.\n\nThe underlying technology in the PM1 will be built upon to look at other measurements within the eye including, axial length, pupillometry and keratometry for use in both human and veterinary optometry.\n\nDisease Screening\nBuilding upon our patented technology, Occuity's disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimer's in non-clinical settings such as high street opticians, pharmacies and care homes.\n\nDisease Monitoring\n\nOccuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor. \n\nInstead of relying on finger stick blood tests to provide blood glucose readings, Occuity is in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.